David M Gooden

This inventor holds 16 USPTO granted patents and 9 published patent applications and 5 EPO patents, primarily in Ophthalmic Treatments. Top assignees: Duke University, Encore Health LLC, Immunolight, LLC. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David M Gooden. Retrieved from https://idiyas.com/inventor/david-m-gooden

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 9)

% Patents Active = 75.0

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 99(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...

Areas of Expertise:

Ophthalmic Diseases

Psoralen Derivatives

Cell Proliferation

Dithiol Compounds

Choline Esters

CaMKK2 Disorders

Arylcyclopropylamine

Lipoic Acid Derivatives

Combination Therapy

Nitroxyl Ion Source

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12221447 - Methods and compositions for drugs to treat ophthalmic diseases (2025-02-11),

2. 11452884 - Methods and systems for treating cell proliferation disorders with psoralen derivatives (2022-09-27),

3. 10336750 - Composition and methods for the treatment of CaMKK2-mediated disorders (2019-07-02),

4. 10039743 - Method of treating presbyopia using dithiol compounds and their derivatives (2018-08-07),

5. 9879005 - Composition and methods for the treatment of CaMKK2-mediated disorders (2018-01-30),

6. 9585850 - Methods of treatment using arylcyclopropylamine compounds (2017-03-07),

7. 9567314 - Dithiol compounds, derivatives, and uses therefor (2017-02-14),

8. 9439897 - Use of psoralen derivatives and combination therapy for treatment of cell proliferation disorders (2016-09-13),

9. 9326970 - Choline esters (2016-05-03),

10. 9284305 - Methods of treating ocular diseases using derivatives of lipoic acid (2016-03-15),

11. 8907109 - Methods and systems for treating cell proliferation disorders with psoralen derivatives (2014-12-09),

12. 8795706 - Methods of treating ocular diseases using derivatives of lipoic acid (2014-08-05),

13. 8791275 - Methods and systems for treating cell proliferation disorders with psoralen derivatives (2014-07-29),

14. 8410162 - Choline esters (2013-04-02),

15. 8383836 - Methods and systems for treating cell proliferation disorders with psoralen derivatives (2013-02-26),

Title: Innovations and Contributions of David M Gooden

Introduction

David M Gooden is a prominent inventor based in Durham, NC, with a remarkable portfolio of 16 patents. His work primarily focuses on developing methods and compositions for treating various ophthalmic diseases, showcasing his commitment to advancing medical science.

Latest Patents

One of Gooden's latest patents involves methods and compositions for drugs aimed at treating CaMKK2-mediated ophthalmic diseases. This patent addresses a range of conditions, including ocular surface inflammatory diseases, uveitis, and retinal diseases. The disclosed compounds demonstrate significant improvements over existing treatments, such as enhanced aqueous solubility and the elimination of non-binding isomers during production. Another notable patent pertains to methods and systems for treating cell proliferation disorders using psoralen derivatives, which further highlights his innovative approach to medical challenges.

Career Highlights

Throughout his career, David M Gooden has made significant contributions to the field of ophthalmology. He has worked with esteemed institutions, including Duke University and Encore Health LLC, where he has applied his expertise to develop groundbreaking treatments.

Collaborations

Gooden has collaborated with notable individuals in his field, including William Garner and Margaret Garner. These partnerships have likely enriched his research and contributed to the success of his innovative projects.

Conclusion

David M Gooden's contributions to the field of ophthalmology through his patents and collaborations reflect his dedication to improving healthcare. His innovative methods and compositions continue to pave the way for advancements in treating complex medical conditions.

Profile summary based on public USPTO records.